NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
“The remaining proceeds from our recent financing further strengthened our balance sheet and our ability to execute the long-range plan we presented at our investor day held last month in New York ...
MassDevice9h
First patient enrolled in IDE study of Conformal Medical’s next-gen LAAO device
Conformal Medical today announced on social media that the first U.S. site enrolled a patient in a trial of its next-gen ...
medtechdive9h
Device industry scrambles as FDA job cuts cause delays
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
JD Supra10h
Rhode Island Cannabis Update: Current Market, Proposed Rules and New Business Opportunities
Cannabis policy reform in Rhode Island has spanned nearly two decades, starting with the legalization of medical marijuana in ...
JD Supra11h
Foreign Drug and Medical Device Manufacturers Under a Second Trump Administration: Increased Enforcement Scrutiny?
As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...
Medical Device Industry Protests Firings of FDA Workers
The group that represents medical device makers in Washington is coming out against the Trump administration’s firings of ...
ChemDAQ partners with customers to facilitate compliance with EPA FIFRA Interim Decision on Ethylene Oxide
In January, the U.S. Environmental Protection Agency (EPA) released its interim decision under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) regarding the use of ethylene oxide (EtO) ...
Saladax Biomedical Inc. Appoints Regulatory and Quality Expert Ms. Stacie Geffner-Atiya as Director of Regulatory and Quality
Ms. Geffner-Atiya holds a Bachelor of Science degree from the State University of New York at Brockport. In her new role, she will oversee regulatory compliance, quality assurance, and global ...